Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
| Brand name | CINACALCET |
| Generic name | CINACALCET |
| Active ingredient(s) | CINACALCET HYDROCHLORIDE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-369-30 |
| Full product label | Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India., NDC 43598-369-30. |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | USA Nationwide. |
| Quantity | 10584 bottles |
| Recall initiated | 2024-10-09 |
| Report date | 2024-11-06 |
| Recall completed | — |
| Recall number | D-0028-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗